Full text
PDFPage 1352
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Edwards I. R., Coulter D. M., Beasley D. M., MacIntosh D. Captopril: 4 years of post marketing surveillance of all patients in New Zealand. Br J Clin Pharmacol. 1987 May;23(5):529–536. doi: 10.1111/j.1365-2125.1987.tb03088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gavras I., Gavras H. Captopril and enalapril. Ann Intern Med. 1983 Apr;98(4):556–557. doi: 10.7326/0003-4819-98-4-556_2. [DOI] [PubMed] [Google Scholar]
- Goodfield M. J., Millard L. G. Severe cutaneous reactions to captopril. Br Med J (Clin Res Ed) 1985 Apr 13;290(6475):1111–1111. doi: 10.1136/bmj.290.6475.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Navis G. J., de Jong P. E., Kallenberg C. G., de Monchy J., de Zeeuw D. Absence of cross-reactivity between captopril and enalapril. Lancet. 1984 May 5;1(8384):1017–1017. doi: 10.1016/s0140-6736(84)92353-5. [DOI] [PubMed] [Google Scholar]
- Wilkin J. K., Hammond J. J., Kirkendall W. M. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol. 1980 Aug;116(8):902–905. [PubMed] [Google Scholar]